NCT03460769View on ClinicalTrials.gov

Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)

RecruitingOBSERVATIONAL
Enrollment

775

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Pancreatic CancerChronic PancreatitisDiabetes Mellitus Type 3c
Interventions
OTHER

Data Management and Monitoring

The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer responsible for the coordination and data management for the Evaluation of a mixed meal test for Diagnosis and characterization of Type 3c diabetes mellitus secondary to pancreatic cancer and chronic pancreatitis (DETECT), which is part of the NIH U01 funded Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC).

Trial Locations (1)

77030

RECRUITING

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

M.D. Anderson Cancer Center

OTHER